Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza.

ABSTRACT:

Background

Data on ventilator associated pneumonia (VAP) in COVID-19 and influenza patients admitted to intensive care units (ICU) are scarce. This study aimed to estimate day-60 mortality related to VAP in ICU patients ventilated for at least 48 h, either for COVID-19 or for influenza, and to describe the epidemiological characteristics in each group of VAP.

Design

Multicentre retrospective observational study.

Setting

Eleven ICUs of the French OutcomeRea^™ network.

Patients

Patients treated with invasive mechanical ventilation (IMV) for at least 48 h for either COVID-19 or for flu.

Results

Of the 585 patients included, 503 had COVID-19 and 82 had influenza between January 2008 and June 2021. A total of 232 patients, 209 (41.6%) with COVID-19

SUBMITTER: Laurichesse G 

PROVIDER: S-EPMC10616026 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature